Associated Papers
Detection of TERT Promoter Mutations in Papillary Thyroid Carcinoma Using Droplet Digital PCR and Their Association with Aggressive Tumor Features.
Lee J et al.
International Journal of Molecular Sciences, 2026
Disease-Specific and Histological Outcomes of Preoperative TERT Promoter Mutation Detected in Isolation or in Combination with Other Mutations in Thyroid Neoplasms.
Calcaterra M et al.
Thyroid : Official Journal of the American Thyroid Association, 2025
Catching the Silent Culprits: TERT Promoter Mutation Screening of Minimally Invasive Follicular and Oncocytic Thyroid Carcinoma in Clinical Practice.
Hellgren LS et al.
Endocrine Pathology, 2024
Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.
Soares P et al.
Endocrine Pathology, 2021
EIF1AX c.338-2A>T splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion.
Castagna MG et al.
Archives of Endocrinology and Metabolism, 2020
Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case.
Stenman A et al.
Endocrine Pathology, 2020
Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease.
Hysek M et al.
Cancers, 2019
Evolutionary history of human colitis-associated colorectal cancer.
Baker AM et al.
Gut, 2019
29991641 (PubMed )
Supplement: gutjnl-2018-316191supp005.xlsx › CD01
TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours-three examples from the clinical routine.
Hysek M et al.
Virchows Archiv : an International Journal of Pathology, 2018
Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report.
Pani F et al.
Oncology Letters, 2017
Select a paper to view details